Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 in TSA and Abdominoplasty
NCT05109312Phase 4Active, not recruiting
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Oct 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Heron Therapeutics, Inc.. Started Oct 2021; status: active, not recruiting.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05109312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109312.